Related Experiment Video
Updated: May 25, 2026
09:38
Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
[Genetic polymorphism of apolipoprotein E in a Peruvian population]
Victoria Marca1, Oscar Acosta, Mario Cornejo-Olivas
1Servicio de Neurogenética, Instituto Nacional de Ciencias Neurológicas, Lima, Perú. peru.neurogenetica@gmail.com
Revista Peruana De Medicina Experimental Y Salud Publica
|January 14, 2012
Summary
The APOE gene
Area of Science:
- Population genetics
- Human genetics
Context:
- The apolipoprotein E (APOE) gene plays a crucial role in lipid metabolism and is associated with various diseases.
- Understanding APOE allele frequencies is vital for population-specific health risk assessments.
Purpose:
- To determine the allelic and genotypic frequencies of the APOE gene in a Peruvian population sample.
- To analyze genetic diversity and population structure related to APOE polymorphism.
Summary:
- This study investigated APOE allele frequencies in 189 healthy Peruvian volunteers.
- The APOE ε3 allele was most frequent (93.9%), with low frequencies of ε4 (5%) and ε2 (1.1%).
- Genetic diversity analysis indicated proximity among the studied groups.
Impact:
- Findings reveal unique APOE allele distributions in Peru compared to global populations.
- The high frequency of APOE ε3 and low frequency of ε4 may have implications for neurological and cardiovascular disease risks in Peru.
- This data provides a baseline for future genetic association studies in the region.
More Related Videos
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...